Symbols / KZR $7.42 -0.40% Kezar Life Sciences, Inc.

Healthcare • Biotechnology • United States • NCM
KZR Chart
About

Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases in the United States. The company's lead product candidate is zetomipzomib (KZR-616), a selective immunoproteasome inhibitor for various indications, including lupus nephritis, dermatomyositis, and polymyositis; and Phase 1b/2 clinical trials in systemic lupus erythematosus. It is also developing KZR-261, a novel first-in-class protein secretion inhibitor for the treatment of tumors resistant to traditional chemotherapeutics. Kezar Life Sciences, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 54.70M
Enterprise Value -14.86M Income -56.03M Sales —
Book/sh 9.56 Cash/sh 9.75 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E — Forward P/E -2.78 PEG —
P/S — P/B 0.78 P/C —
EV/EBITDA 0.29 EV/Sales — Quick Ratio 11.23
Current Ratio 11.52 Debt/Eq 3.32 LT Debt/Eq —
EPS (ttm) -7.66 EPS next Y -2.67 EPS Growth —
Revenue Growth — Earnings 2026-05-12 ROA -29.52%
ROE -59.93% ROIC — Gross Margin 0.00%
Oper. Margin 0.00% Profit Margin 0.00% Shs Outstand 7.37M
Shs Float 5.14M Short Float 2.68% Short Ratio 4.73
Short Interest — 52W High 7.55 52W Low 3.53
Beta 0.51 Avg Volume 54.67K Volume 107.34K
Target Price $6.00 Recom None Prev Close $7.45
Price $7.42 Change -0.40%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$6.00
Mean price target
2. Current target
$7.42
Latest analyst target
3. DCF / Fair value
$-71.18
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$7.42
Low
$5.00
High
$7.00
Mean
$6.00

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2025-10-17 down Jefferies Buy → Hold $7
2025-10-17 down William Blair Outperform → Market Perform —
2025-10-17 main Wells Fargo Equal-Weight → Equal-Weight $5
2025-07-16 reit HC Wainwright & Co. Neutral → Neutral —
2024-12-19 main Wells Fargo Equal-Weight → Equal-Weight $9
2024-12-02 reit HC Wainwright & Co. Neutral → Neutral —
2024-11-14 main Wells Fargo Equal-Weight → Equal-Weight $11
2024-10-18 reit HC Wainwright & Co. — → Neutral —
2024-10-14 reit HC Wainwright & Co. — → Neutral —
2024-10-02 down HC Wainwright & Co. Buy → Neutral —
2024-08-14 reit HC Wainwright & Co. Buy → Buy $7
2024-07-22 main HC Wainwright & Co. Buy → Buy $7
2024-05-10 reit HC Wainwright & Co. Buy → Buy $20
2024-03-15 reit HC Wainwright & Co. Buy → Buy $20
2023-12-04 reit HC Wainwright & Co. Buy → Buy $20
2023-11-27 reit HC Wainwright & Co. Buy → Buy $20
2023-11-14 main Wells Fargo Equal-Weight → Equal-Weight $2
2023-10-12 reit HC Wainwright & Co. Buy → Buy $20
2023-10-05 down JonesTrading Buy → Hold —
2023-09-25 main HC Wainwright & Co. Buy → Buy $20
News
RSS: Latest KZR news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2025-07-02 SCHILLER MARK C Chief Operating Officer — 561 $4.28 $2,401
2025-07-02 CHIANG PICHI LUO Officer — 264 $4.28 $1,130
2024-07-02 SCHILLER MARK C Officer — 6,688 $0.58 $3,879
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
0.00
-100.00%
7.00
0.00
0.00
Operating Revenue
0.00
-100.00%
7.00
0.00
0.00
Operating Expense
89.14
-20.58%
112.24
+57.72%
71.16
+30.19%
54.66
Research And Development
65.74
-23.29%
85.70
+68.00%
51.01
+31.01%
38.94
Selling General And Administration
23.39
-11.86%
26.54
+31.69%
20.15
+28.17%
15.72
General And Administrative Expense
23.39
-11.86%
26.54
+31.69%
20.15
+28.17%
15.72
Other Gand A
23.39
-11.86%
26.54
+31.69%
20.15
+28.17%
15.72
Total Expenses
89.14
-20.58%
112.24
+57.72%
71.16
+30.19%
54.66
Operating Income
-89.14
+15.30%
-105.24
-47.88%
-71.16
-30.19%
-54.66
Total Operating Income As Reported
-90.61
+18.68%
-111.42
-56.58%
-71.16
-30.19%
-54.66
EBITDA
-81.10
+18.29%
-99.25
-50.31%
-66.03
-24.68%
-52.96
Normalized EBITDA
-79.63
+14.43%
-93.07
-40.94%
-66.03
-24.68%
-52.96
Reconciled Depreciation
1.04
-2.44%
1.07
+4.20%
1.02
-32.25%
1.51
EBIT
-82.14
+18.12%
-100.32
-49.61%
-67.05
-23.10%
-54.47
Total Unusual Items
-1.47
+76.24%
-6.19
0.00
0.00
Total Unusual Items Excluding Goodwill
-1.47
+76.24%
-6.19
0.00
0.00
Special Income Charges
-1.47
+76.24%
-6.19
0.00
0.00
Restructuring And Mergern Acquisition
-0.08
-102.41%
3.28
0.00
0.00
Write Off
1.55
-46.73%
2.91
—
—
Net Income
-83.74
+17.80%
-101.87
-49.28%
-68.24
-24.91%
-54.63
Pretax Income
-83.74
+17.80%
-101.87
-49.28%
-68.24
-24.91%
-54.63
Net Non Operating Interest Income Expense
6.87
-28.10%
9.55
+226.86%
2.92
+9979.31%
0.03
Interest Expense Non Operating
1.59
+2.77%
1.55
+30.80%
1.19
+645.28%
0.16
Net Interest Income
6.87
-28.10%
9.55
+226.86%
2.92
+9979.31%
0.03
Interest Expense
1.59
+2.77%
1.55
+30.80%
1.19
+645.28%
0.16
Interest Income Non Operating
8.46
-23.79%
11.10
+170.30%
4.11
+2085.11%
0.19
Interest Income
8.46
-23.79%
11.10
+170.30%
4.11
+2085.11%
0.19
Other Income Expense
-1.47
+76.24%
-6.19
—
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-83.74
+17.80%
-101.87
-49.28%
-68.24
-24.91%
-54.63
Net Income From Continuing Operation Net Minority Interest
-83.74
+17.80%
-101.87
-49.28%
-68.24
-24.91%
-54.63
Net Income From Continuing And Discontinued Operation
-83.74
+17.80%
-101.87
-49.28%
-68.24
-24.91%
-54.63
Net Income Continuous Operations
-83.74
+17.80%
-101.87
-49.28%
-68.24
-24.91%
-54.63
Normalized Income
-82.27
+14.02%
-95.68
-40.22%
-68.24
-24.91%
-54.63
Net Income Common Stockholders
-83.74
+17.80%
-101.87
-49.28%
-68.24
-24.91%
-54.63
Diluted EPS
-11.00
+21.65%
-14.04
-39.01%
-10.10
+2.88%
-10.40
Basic EPS
-11.00
+21.65%
-14.04
-39.01%
-10.10
+2.88%
-10.40
Basic Average Shares
7.29
+0.48%
7.26
+7.70%
6.74
+27.69%
5.28
Diluted Average Shares
7.29
+0.48%
7.26
+7.70%
6.74
+27.69%
5.28
Diluted NI Availto Com Stockholders
-83.74
+17.80%
-101.87
-49.28%
-68.24
-24.91%
-54.63
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
144.68
-34.60%
221.24
-26.15%
299.57
+37.46%
217.93
Current Assets
137.49
-33.56%
206.95
-27.57%
285.72
+34.99%
211.65
Cash Cash Equivalents And Short Term Investments
132.25
-34.33%
201.37
-27.19%
276.56
+32.74%
208.35
Cash And Cash Equivalents
41.75
+17.63%
35.49
-12.27%
40.46
-35.66%
62.88
Cash Equivalents
41.14
+16.38%
35.35
—
—
Cash Financial
0.61
+322.92%
0.14
—
—
Other Short Term Investments
90.50
-45.44%
165.88
-29.74%
236.10
+62.30%
145.47
Receivables
0.94
-66.46%
2.80
—
—
Other Receivables
0.51
-75.55%
2.10
—
—
Accrued Interest Receivable
0.42
-38.99%
0.69
—
—
Prepaid Assets
3.95
+56.28%
2.53
-72.38%
9.16
+256.46%
2.57
Other Current Assets
0.35
+39.84%
0.25
-72.72%
0.92
+26.20%
0.73
Total Non Current Assets
7.19
-49.64%
14.29
+3.17%
13.85
+120.51%
6.28
Net PPE
4.78
-45.01%
8.69
-34.03%
13.17
+119.64%
6.00
Gross PPE
11.22
-20.45%
14.11
-20.61%
17.77
+84.21%
9.65
Accumulated Depreciation
-6.45
-18.91%
-5.42
-17.77%
-4.60
-26.01%
-3.65
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
5.85
+0.10%
5.84
+25.22%
4.67
+27.27%
3.67
Other Properties
1.89
-60.53%
4.78
-50.95%
9.74
+258.92%
2.71
Leases
3.49
+0.00%
3.49
+3.62%
3.37
+3.00%
3.27
Non Current Accounts Receivable
1.74
—
—
—
Non Current Prepaid Assets
0.67
-87.66%
5.46
—
—
Other Non Current Assets
—
0.13
-80.12%
0.67
+139.01%
0.28
Total Liabilities Net Minority Interest
27.77
-17.52%
33.66
+13.37%
29.70
+41.03%
21.06
Current Liabilities
20.33
+14.57%
17.74
+61.35%
11.00
+33.91%
8.21
Payables And Accrued Expenses
8.87
-19.54%
11.02
+113.15%
5.17
+2.56%
5.04
Payables
3.65
-55.75%
8.25
+232.84%
2.48
+22.24%
2.03
Accounts Payable
3.65
-55.75%
8.25
+232.84%
2.48
+22.24%
2.03
Current Accrued Expenses
5.22
+88.21%
2.77
+2.97%
2.69
-10.68%
3.02
Pensionand Other Post Retirement Benefit Plans Current
2.72
-26.75%
3.71
+13.74%
3.26
+65.48%
1.97
Current Debt And Capital Lease Obligation
8.74
+190.27%
3.01
+17.43%
2.56
+113.93%
1.20
Current Debt
5.22
—
—
—
Other Current Borrowings
5.22
—
—
—
Current Capital Lease Obligation
3.53
+17.07%
3.01
+17.43%
2.56
+113.93%
1.20
Other Current Liabilities
—
0.11
-60.00%
0.27
+167.68%
0.10
Total Non Current Liabilities Net Minority Interest
7.44
-53.29%
15.92
-14.86%
18.70
+45.57%
12.85
Long Term Debt And Capital Lease Obligation
7.44
-53.29%
15.92
-14.86%
18.70
+45.57%
12.85
Long Term Debt
5.11
-49.24%
10.07
+2.39%
9.83
+2.20%
9.62
Long Term Capital Lease Obligation
2.33
-60.25%
5.85
-33.99%
8.87
+175.05%
3.22
Stockholders Equity
116.92
-37.67%
187.57
-30.50%
269.87
+37.08%
196.88
Common Stock Equity
116.92
-37.67%
187.57
-30.50%
269.87
+37.08%
196.88
Capital Stock
0.01
+0.00%
0.01
-89.71%
0.07
+21.43%
0.06
Common Stock
0.01
+0.00%
0.01
-89.71%
0.07
+21.43%
0.06
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
7.30
+0.35%
7.28
+6.26%
6.85
+21.74%
5.63
Ordinary Shares Number
7.30
+0.35%
7.28
+6.26%
6.85
+21.74%
5.63
Additional Paid In Capital
551.57
+2.44%
538.46
+3.62%
519.62
+37.55%
377.76
Retained Earnings
-434.50
-23.87%
-350.76
-40.93%
-248.89
-37.77%
-180.65
Gains Losses Not Affecting Retained Earnings
-0.16
-24.62%
-0.13
+85.92%
-0.92
-217.18%
-0.29
Other Equity Adjustments
-0.16
-24.62%
-0.13
+85.92%
-0.92
-217.18%
-0.29
Total Equity Gross Minority Interest
116.92
-37.67%
187.57
-30.50%
269.87
+37.08%
196.88
Total Capitalization
122.03
-38.26%
197.64
-29.34%
279.71
+35.45%
206.50
Working Capital
117.16
-38.08%
189.21
-31.13%
274.73
+35.04%
203.44
Invested Capital
127.24
-35.62%
197.64
-29.34%
279.71
+35.45%
206.50
Total Debt
16.18
-14.54%
18.93
-10.96%
21.26
+51.41%
14.04
Capital Lease Obligations
5.85
-33.98%
8.86
-22.45%
11.43
+158.48%
4.42
Net Tangible Assets
116.92
-37.67%
187.57
-30.50%
269.87
+37.08%
196.88
Tangible Book Value
116.92
-37.67%
187.57
-30.50%
269.87
+37.08%
196.88
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-74.21
+9.10%
-81.64
-38.74%
-58.85
-38.67%
-42.44
Cash Flow From Continuing Operating Activities
-74.21
+9.10%
-81.64
-38.74%
-58.85
-38.67%
-42.44
Net Income From Continuing Operations
-83.74
+17.80%
-101.87
-49.28%
-68.24
-24.91%
-54.63
Depreciation Amortization Depletion
1.04
-2.44%
1.07
+4.20%
1.02
-32.25%
1.51
Depreciation And Amortization
1.04
-2.44%
1.07
+4.20%
1.02
-32.25%
1.51
Other Non Cash Items
0.27
+12.18%
0.24
+6.25%
0.22
+146.15%
0.09
Stock Based Compensation
13.01
-28.26%
18.14
+29.49%
14.01
+84.39%
7.60
Asset Impairment Charge
1.55
-46.73%
2.91
0.00
0.00
Operating Gains Losses
—
—
0.01
—
Gain Loss On Sale Of PPE
—
—
0.01
0.00
Change In Working Capital
-1.30
-127.62%
4.71
+205.54%
-4.46
-463.70%
1.23
Change In Prepaid Assets
0.34
-90.65%
3.58
+161.91%
-5.79
-650.62%
1.05
Change In Payables And Accrued Expense
-3.15
-149.57%
6.35
+249.89%
1.81
+49.06%
1.22
Change In Other Working Capital
-1.67
-450.83%
-0.30
-222.34%
-0.09
+90.98%
-1.04
Change In Other Current Assets
3.18
+164.62%
-4.92
-1155.36%
-0.39
0.00
Change In Other Current Liabilities
—
—
-0.09
+90.98%
-1.04
Investing Cash Flow
80.43
+5.76%
76.05
+183.21%
-91.39
-221.31%
-28.44
Cash Flow From Continuing Investing Activities
80.43
+5.76%
76.05
+183.21%
-91.39
-221.31%
-28.44
Net PPE Purchase And Sale
-0.03
+98.39%
-1.80
-14.39%
-1.58
-399.37%
-0.32
Purchase Of PPE
-0.03
+98.40%
-1.81
-14.70%
-1.58
-399.37%
-0.32
Sale Of PPE
0.00
-100.00%
0.01
0.00
0.00
Capital Expenditure
-0.03
+98.40%
-1.81
-14.70%
-1.58
-399.37%
-0.32
Net Investment Purchase And Sale
80.46
+3.35%
77.85
+186.68%
-89.81
-219.30%
-28.13
Purchase Of Investment
-91.34
+49.37%
-180.40
+45.70%
-332.20
-112.44%
-156.38
Sale Of Investment
171.79
-33.48%
258.25
+6.54%
242.39
+89.00%
128.25
Financing Cash Flow
0.10
-83.86%
0.64
-99.50%
127.86
+13.57%
112.58
Cash Flow From Continuing Financing Activities
0.10
-83.86%
0.64
-99.50%
127.86
+13.57%
112.58
Net Issuance Payments Of Debt
—
0.00
0.00
-100.00%
9.53
Issuance Of Debt
—
0.00
0.00
-100.00%
9.53
Long Term Debt Issuance
—
0.00
0.00
-100.00%
9.53
Net Long Term Debt Issuance
—
0.00
0.00
-100.00%
9.53
Net Common Stock Issuance
0.00
0.00
-100.00%
126.54
+25.33%
100.97
Proceeds From Stock Option Exercised
0.10
-83.86%
0.64
-51.63%
1.32
-36.71%
2.08
Changes In Cash
6.32
+227.37%
-4.96
+77.83%
-22.38
-153.66%
41.70
Effect Of Exchange Rate Changes
-0.06
-3050.00%
-0.00
+95.92%
-0.05
+2.00%
-0.05
Beginning Cash Position
35.49
-12.27%
40.46
-35.66%
62.88
+196.22%
21.23
End Cash Position
41.75
+17.63%
35.49
-12.27%
40.46
-35.66%
62.88
Free Cash Flow
-74.24
+11.04%
-83.45
-38.12%
-60.42
-41.33%
-42.75
Interest Paid Supplemental Data
1.33
+1.52%
1.31
+35.15%
0.97
+1310.14%
0.07
Amortization Of Securities
-5.04
+26.16%
-6.83
-387.51%
-1.40
-179.15%
1.77
Common Stock Issuance
0.00
0.00
-100.00%
126.54
+25.33%
100.97
Issuance Of Capital Stock
0.00
0.00
-100.00%
126.54
+25.33%
100.97
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category